Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFirst Affiliated Hospital of Harbin Medical University

About this trial

This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.

Eligibility criteria

Qualifiers

Patients with inflammatory bowel disease; aged 18-80 years; all cases agreed to participate in the study.

Healthy volunteers who agreed to participate in the study.

Disqualifiers

Patients with severe heart disease; patients with severe kidney disease; patients with low blood pressure; patients with severe infections such as sepsis or pneumonia; patients who have used immunosuppressants such as 6-mercaptopurine, imidazole thiopurine, and cyclosporine within a short period, and women during pregnancy; patients who are post-colon resected; patients who disagreed to participate in the study.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

90 Participants
are grouped into 2 trial groups